These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 4108370)
41. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive. Christie GA Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973 [No Abstract] [Full Text] [Related]
42. Effect of switching with oral contraceptives. Wassef SA; Sami G; Hamid EA Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511 [TBL] [Abstract][Full Text] [Related]
43. Microdose intrauterine progestagen associated with intrauterine contraceptive devices. Horne HW; Scott JM; Underwood RH Int J Fertil; 1970; 15(4):210-3. PubMed ID: 5487545 [TBL] [Abstract][Full Text] [Related]
44. CHLORMADINONE, A POTENT SYNTHETIC ORAL PROGESTIN: EVALUATION OF 1002 CYCLES. BALIN H; WAN LS Int J Fertil; 1965; 10():127-36. PubMed ID: 14291546 [No Abstract] [Full Text] [Related]
46. [The effect of intrauterine contraceptive devices on the endometrium]. Sheppard BL; Bonnar J Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565 [TBL] [Abstract][Full Text] [Related]
47. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium. Kreitmann B; Bugat R; Bayard F J Clin Endocrinol Metab; 1979 Dec; 49(6):926-9. PubMed ID: 92478 [TBL] [Abstract][Full Text] [Related]
48. [Histological and coagulation analytical studies on the effect of continuous low-dose gestagen administration on the endometrium]. Staffeldt K; Kreuzer G; Hoffbauer H Arch Gynakol; 1969; 207(1):50-2. PubMed ID: 4184754 [No Abstract] [Full Text] [Related]
49. Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles. Rabe T; Hartschuh E; Wahlstrom T; Höschen K; König S Contraception; 2010 Oct; 82(4):358-65. PubMed ID: 20851230 [TBL] [Abstract][Full Text] [Related]
50. Contraceptive treatment with chlormadinone and its effect on the endometrium. A histological investigation. Kühne D; Seidl S; Göretzlehner G Endokrinologie; 1972 May; 59(3):295-306. PubMed ID: 4116092 [TBL] [Abstract][Full Text] [Related]
51. Intrauterine chemical release. Br Med J; 1974 Oct; 4(5938):181-2. PubMed ID: 4418090 [No Abstract] [Full Text] [Related]
52. [The effect of different doses of chlormadinone on the vaginal epithelium, the endometrium and the cervical mucus]. Binkiewicz B; Jedrzejewski M; Krzywdziński K; Teter J; Witkowski L Endokrynol Pol; 1970; 21(2):163-74. PubMed ID: 4192897 [No Abstract] [Full Text] [Related]
56. Progress in the development of the Progestasert TM 65 progesterone therapeutic system for contraception. Place VA; Pharriss BB J Reprod Med; 1974 Aug; 13(2):66-8. PubMed ID: 4844516 [TBL] [Abstract][Full Text] [Related]
57. Antifertility effect of continuous low-dosage oral progestogen therapy. Zañartu J; Rodriguez-Moore G; Pupkin M; Salas O; Guerrero R Br Med J; 1968 May; 2(5600):263-6. PubMed ID: 4171573 [No Abstract] [Full Text] [Related]
58. Intrauterine contraception with the copper 7 device. Barreca P; Cittadini E Acta Eur Fertil; 1974 Mar; 5(1):1-24. PubMed ID: 4846195 [No Abstract] [Full Text] [Related]
59. [Vaginal and intrauterine contraception]. Serfaty D Rev Prat; 1995 Dec; 45(19):2407-15. PubMed ID: 8571052 [TBL] [Abstract][Full Text] [Related]
60. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive. Ringrose CA J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]